197 related articles for article (PubMed ID: 20228278)
1. Multiplex enzyme assays and inhibitor screening by mass spectrometry.
Rathore R; Pribil P; Corr JJ; Seibel WL; Evdokimov A; Greis KD
J Biomol Screen; 2010 Sep; 15(8):1001-7. PubMed ID: 20228278
[TBL] [Abstract][Full Text] [Related]
2. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
[TBL] [Abstract][Full Text] [Related]
3. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
[TBL] [Abstract][Full Text] [Related]
4. Extending matrix-assisted laser desorption/ionization triple quadrupole mass spectrometry enzyme screening assays to targets with small molecule substrates.
Rathore R; Corr JJ; Lebre DT; Seibel WL; Greis KD
Rapid Commun Mass Spectrom; 2009 Oct; 23(20):3293-300. PubMed ID: 19757451
[TBL] [Abstract][Full Text] [Related]
5. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
[TBL] [Abstract][Full Text] [Related]
6. A visible wavelength spectrophotometric assay suitable for high-throughput screening of 3-hydroxy-3-methylglutaryl-CoA synthase.
Andrew Skaff D; Miziorko HM
Anal Biochem; 2010 Jan; 396(1):96-102. PubMed ID: 19706283
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of laser diode thermal desorption (LDTD) coupled with tandem mass spectrometry (MS/MS) for support of in vitro drug discovery assays: increasing scope, robustness and throughput of the LDTD technique for use with chemically diverse compound libraries.
Beattie I; Smith A; Weston DJ; White P; Szwandt S; Sealey L
J Pharm Biomed Anal; 2012 Feb; 59():18-28. PubMed ID: 22071442
[TBL] [Abstract][Full Text] [Related]
8. Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screens.
Adam GC; Meng J; Rizzo JM; Amoss A; Lusen JW; Patel A; Riley D; Hunt R; Zuck P; Johnson EN; Uebele VN; Hermes JD
J Biomol Screen; 2015 Feb; 20(2):212-22. PubMed ID: 25336354
[TBL] [Abstract][Full Text] [Related]
9. Multiplexing terbium- and europium-based TR-FRET readouts to increase kinase assay capacity.
Horton RA; Vogel KW
J Biomol Screen; 2010 Sep; 15(8):1008-15. PubMed ID: 20460248
[TBL] [Abstract][Full Text] [Related]
10. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
Dasgupta M; Tang W; Caldwell GW; Yan Z
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
[TBL] [Abstract][Full Text] [Related]
11. A mass spectrometry plate reader: monitoring enzyme activity and inhibition with a Desorption/Ionization on Silicon (DIOS) platform.
Shen Z; Go EP; Gamez A; Apon JV; Fokin V; Greig M; Ventura M; Crowell JE; Blixt O; Paulson JC; Stevens RC; Finn MG; Siuzdak G
Chembiochem; 2004 Jul; 5(7):921-7. PubMed ID: 15239048
[TBL] [Abstract][Full Text] [Related]
12. Development of an inhibitor screening platform via mass spectrometry.
Rathore R; Corr J; Scott G; Vollmerhaus P; Greis KD
J Biomol Screen; 2008 Dec; 13(10):1007-13. PubMed ID: 19029013
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry for enzyme assays and inhibitor screening: an emerging application in pharmaceutical research.
Greis KD
Mass Spectrom Rev; 2007; 26(3):324-39. PubMed ID: 17405133
[TBL] [Abstract][Full Text] [Related]
14. Novel in vitro protein fragment complementation assay applicable to high-throughput screening in a 1536-well format.
Hashimoto J; Watanabe T; Seki T; Karasawa S; Izumikawa M; Seki T; Iemura S; Natsume T; Nomura N; Goshima N; Miyawaki A; Takagi M; Shin-Ya K
J Biomol Screen; 2009 Sep; 14(8):970-9. PubMed ID: 19641222
[TBL] [Abstract][Full Text] [Related]
15. Development of a high-throughput online solid-phase extraction/tandem mass spectrometry method for cytochrome P450 inhibition screening.
Lim KB; Ozbal CC; Kassel DB
J Biomol Screen; 2010 Apr; 15(4):447-52. PubMed ID: 20208033
[TBL] [Abstract][Full Text] [Related]
16. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
17. Homogeneous screening assay for human tankyrase.
Narwal M; Fallarero A; Vuorela P; Lehtiö L
J Biomol Screen; 2012 Jun; 17(5):593-604. PubMed ID: 22357873
[TBL] [Abstract][Full Text] [Related]
18. Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors.
Ouertatani-Sakouhi H; Liu M; El-Turk F; Cuny GD; Glicksman MA; Lashuel HA
J Biomol Screen; 2010 Apr; 15(4):347-58. PubMed ID: 20231420
[TBL] [Abstract][Full Text] [Related]
19. High-throughput mass spectrometric cytochrome P450 inhibition screening.
Lim KB; Ozbal CC; Kassel DB
Methods Mol Biol; 2013; 987():25-50. PubMed ID: 23475665
[TBL] [Abstract][Full Text] [Related]
20. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
